跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FIASP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
FIASP
Authorized
STANDARD
FIASP
Novo Nordisk Canada Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e1a82825c2be315f
Company
Novo Nordisk Canada Inc
Type
Standard
Approval Details
Approval Id
e1a82825c2be315f
Drug Approval Canada Name
FIASP
Product Name
FIASP
Status
Marketed
Status Date
2017-03-03
Original Market Date
2017-03-03
Din
02460416
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Schedule D
Ahfs
68:20.08
Atc Original
A10AB05 INSULIN ASPART
Atc Name
a 10 ab 05
Aig Number
0144802001
Company Name
Novo Nordisk Canada Inc
Company Address
101-2476 Argentia Road, Mississauga, Ontario, Canada, L5N 6M1
Active Ingredients
INSULIN ASPART
100 UNIT / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e1a82825c2be315f
Type
Standard
Back to Health Canada Approvals